Nav: Home

Medical marketing has skyrocketed in the past two decades, while oversight remains limited

January 08, 2019

Healthcare spending in the United States is the highest in the world: totaling $3.3 trillion--or 17.8% of the GDP--in 2016. To capture market share--and to expand the market--drug companies and healthcare organizations use a wide array of promotional activities, including TV and digital advertising, social media, disease awareness campaigns targeting consumers, and marketing to professionals via free drug samples or consulting payments. In an article recently published in the Journal of American Medical Association (JAMA), researchers from The Dartmouth Institute for Health Policy and Clinical Practice reviewed medical marketing (the marketing of prescription drugs, disease awareness, laboratory tests and health services to consumers and professionals) over a 20-year period from 1997 through 2016 and found that while it had increased dramatically from about $17.7 billion to $29.9 billion, regulation has not.

"Because the goal of medical marketing is to shape our perceptions of the benefits and harms of drugs, treatments, and even of diseases, themselves, it can have a very significant impact on healthcare and can even hamper efforts to control unsustainable healthcare spending," says Dartmouth Institute Professor Steven Woloshin, MD, who co-authored the paper with his wife and longtime research partner, the late Professor Lisa Schwartz, MD. (Dr. Schwartz passed away in November of 2018).

In their review of spending, Schwartz and Woloshin found that the most rapid increase was in direct-to-consumer (DTC) advertising, which increased from $2.1 billion (11.9% of total spending) in 1997 to $9.6 billion (32% of total spending) in 2016.

Other findings on DTC spending during this period include:
  • DTC prescription drug advertising increased from $1.3 billion (79,000 ads) to $6 billion (4.6 million ads, including 663,000 TV commercials), with a shift toward high-cost biologics and cancer immunotherapies.

  • Disease awareness campaigns by pharmaceutical companies increased from 44 to 401 and spending on them increased from $177 million to $430 million.

  • DTC advertising for health services increased from $542 million to $2.9 billion, with the largest spending increases by hospitals, dental centers, cancer centers, mental health and addiction centers, and medical services, such as home health.

  • DTC spending on advertising for laboratory tests (such as genetic testing) increased from $75.4 million to $82.6 million; although due to less expensive electronic media advertising the number of ads increased more significantly from 14,100 to 255,300.

  • In 1997, DTC ad spending for lab testing was almost exclusively for pregnancy/fertility tests, HIV tests, and glucose monitors, whereas, by 2016, 64% of DTC ad spending was for genetic tests. AncestryDNA, the highest advertiser spent $38 million in 2016.
While marketing to healthcare professionals rose less rapidly than DTC advertising, promotional activities did increase in most areas. Marketing to healthcare professionals by drug companies accounted for most of the promotional spending, with an increase from $15.6 billion to $20.3 billion during this period.

Other findings include:
  • Spending on product detailing (typically face-to-face office and hospital visits by pharmaceutical company sales reps) to professionals was similar in 1997 and 2016, approximately $5 billion.

  • Spending on free drug samples increased from $8.9 billion in 1997 to $13.5 billion in 2016.

  • One of the few areas where spending decreased was in medical journal advertising, which declined from $744 million in 1997 to $119 million in 2016.
While the FDA's Office of Prescription Drug Promotion (OPDP) is responsible for reviewing prescription drug advertising and related promotional materials to ensure their veracity, other organizations, such as the U.S. Department of Justice's Consumer Protection Branch and the State Attorneys General offices also are involved in curbing misleading promotion. When reviewing regulatory activity from 1997-2016, Schwartz and Woloshin found the number of consumer and professional drug promotional materials which companies submitted for FDA review increased from 34,182 to 97,252. Yet, FDA violation letters for misleading drug marketing decreased from 156 to 11. While there have been 103 financial settlements between drug companies and federal and state governments since 1997--resulting in more than $11 billion in fines for deceptive or off-label marketing practices--the Federal Trade Commission (FTC) has acted against misleading marketing only in the case of a single for-profit cancer center.

"I think our findings highlight that there is a lot of room to be more active in regulating medical marketing. Enacting better oversight of product detailing or adding tables that quantify the benefits and adverse effects of drugs to advertising are two examples we cited in the paper, but there are many feasible steps that could be taken which could potentially improve the quality of health information and cut back on overprescribing and unnecessary medical spending," Woloshin says.
-end-


The Dartmouth Institute for Health Policy & Clinical Practice

Related Healthcare Articles:

Mitochondrial disease has a disproportionate healthcare burden in US
Mitochondrial diseases are a diverse group of disorders caused by mutated genes that impair energy production in a patient's cells, often with severe effects.
Healthcare providers should individualize patient education
Health information should be tailored to a patient's ability to understand health concepts and keep them motivated to maintain long-term changes.
High prevalence of CRE in Washington, D.C. healthcare facilities
Carbapenem-resistant Enterobacteriaceae (CRE), a family of highly pathogenic antibiotic-resistant organisms, are endemic across Washington, D.C. healthcare facilities, with 5.2 percent of inpatients testing positive for the bacteria, according to new research published online today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
Better, cheaper healthcare with dry blood samples
A drop of blood on filter paper, allowed to dry and stored for future diagnostic purposes -- considerably easier than the present-day, resource-consuming method using frozen blood samples in plastic tubes.
Undetected Ebola infection in international healthcare workers very unlikely
Undiagnosed Ebola virus infection was probably very rare in international workers who were deployed during the 2013-2015 outbreak of the virus in West Africa, despite mild and asymptomatic cases of Ebola being known to occur, according to new research led by the London School of Hygiene & Tropical Medicine.
Can we put a price on healthcare innovation in cancer?
Is there evidence that the money spent on innovation 'for the cure' actually benefits cancer patients?
Leaders in Healthcare
Join aspiring leaders to address some of the biggest issues facing healthcare leadership and management in the UK, affecting the professional workforce as well as the population.
New study: Estimated burden of healthcare-associated infections
A study published today by PLOS Medicine, estimates the combined burden of six healthcare-associated infections as being higher than that of diseases such as influenza, HIV/AIDS and tuberculosis together.
Healthcare corruption taken to task by technology, study shows
Mobile phone technology could help to beat bad practices in healthcare delivery, research led by the University of Edinburgh suggests.
Improving LGBT healthcare for military veterans
The U.S. Veterans Health Administration (VHA), which is likely the largest provider of LGBT healthcare in the world, is implementing various system-wide changes aimed at improving LGBT care, including transgender e-consultations to aid interdisciplinary providers and the addition of a self-identified gender identity field to all veteran record systems.

Related Healthcare Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Jumpstarting Creativity
Our greatest breakthroughs and triumphs have one thing in common: creativity. But how do you ignite it? And how do you rekindle it? This hour, TED speakers explore ideas on jumpstarting creativity. Guests include economist Tim Harford, producer Helen Marriage, artificial intelligence researcher Steve Engels, and behavioral scientist Marily Oppezzo.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".